Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 157

Results For "CEO"

1786 News Found

Cipla launches Spirofy for early diagnosis of COPD
Medical Device | November 17, 2021

Cipla launches Spirofy for early diagnosis of COPD

It is India’s first pneumotach based portable wireless Spirometer for diagnosis of Chronic Obstructive Pulmonary Disorder (COPD)


World’s first Donepezil patch to treat Alzheimer approved in South Korea
Biotech | November 17, 2021

World’s first Donepezil patch to treat Alzheimer approved in South Korea

Launching in 2022, its availability will be expanded to the global market


Pre-diabetes is a much more serious issue in India: Fitterfly
News | November 16, 2021

Pre-diabetes is a much more serious issue in India: Fitterfly

Two out of three people under the age of 40 are at risk of prediabetes


Vakrangee to distribute Corival products
Supply Chain | November 15, 2021

Vakrangee to distribute Corival products

Vakrangee’s distribution network across rural India will help penetrate underserved markets


BGS Gleneagles Global hospital opens women’s cancer care centre
Hospitals | November 15, 2021

BGS Gleneagles Global hospital opens women’s cancer care centre

Early detection of breast cancer increases survival rate by 95 per cent


Roche retains its sustainability ranking in the Dow Jones Sustainability Indices
Sustainability | November 15, 2021

Roche retains its sustainability ranking in the Dow Jones Sustainability Indices

The company performed particularly well in operational eco-efficiency, environmental and social reporting


Jubilant HollisterStier plans US $92 mn expansion
News | November 13, 2021

Jubilant HollisterStier plans US $92 mn expansion

The 50,000 square foot expansion will house a high-speed filling line and lyophilizers, which will increase the facility’s sterile injectable capacity by 50%


Sun Pharma to introduce molnupiravir in India
Drug Approval | November 12, 2021

Sun Pharma to introduce molnupiravir in India

The Drug Controller General of India (DCGI), is reviewing clinical data of molnupiravir for the treatment of Covid-19 in adults in India


Solara Active Pharma Sciences PAT slides to Rs 29.71 cr in Q2FY22
News | November 12, 2021

Solara Active Pharma Sciences PAT slides to Rs 29.71 cr in Q2FY22

Solara Active Pharma Sciences has reported consolidated financial results for the period ended September 30, 2021.


J.B Chemicals & Pharmaceuticals PAT at Rs 98 cr. in Q2FY22
News | November 12, 2021

J.B Chemicals & Pharmaceuticals PAT at Rs 98 cr. in Q2FY22

J. B. Chemicals & Pharmaceuticals Limited (JBCPL), announced its financial results for the second quarter ended 30th September, 2021